CSF3 and squamous cell carcinoma: In a randomized, multicentric trial evaluating the preventive effect of granulocyte colony-stimulating factor (G-CSF) in patients receiving hyperfractionated RT or concomitant CRT, there was an unexpected increase in locoregional failures experienced by patients with stage III–IV squamous cell carcinoma of the head and neck area [30].